CLINICAL_TRIALS
trial_result
· 2015-02-13
Clinical Trial Update: Levodopa for the Treatment of Residual Amblyopia [Phase 3]
Summary
Phase 3 trial evaluating levodopa for residual amblyopia has completed and posted results in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED | Results posted: 2015-02-13